{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-048248","form_type":"8-K","ticker":"SNTI","cik":"0001854270","company_name":"Senti Biosciences, Inc.","filed_at":"2026-07-15T11:32:12+00:00","discovered_at":"2026-07-15T11:35:00.231147+00:00","generated_at":"2026-07-15T11:35:21.408235+00:00","sec_items":["1.01","2.02","5.01","7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Senti Biosciences enters merger agreement with Celadon affiliate; stockholders to receive CVRs for SENTI-202 milestones","bullets":["Celadon affiliate to acquire substantially all of Senti's business and pipeline via merger; Senti to remain public with streamlined structure.","Stockholders will receive contingent value rights (CVRs) with potential payments up to $60M based on SENTI-202 BLA filing, FDA approval, and net sales milestones.","Preliminary cash and cash equivalents of $6.5M as of June 30, 2026; combined with $6M additional funding from Celadon expected to fund operations through Q4 2026.","Merger subject to stockholder approval and other conditions; expected to close in Q3 2026.","Celadon, already largest stockholder with 54.6% ownership, could increase to up to 77.5% if additional notes are issued and exchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-048248","json":"https://secwatch.observer/filing/0001628280-26-048248.json","markdown":"https://secwatch.observer/filing/0001628280-26-048248.md","text":"https://secwatch.observer/filing/0001628280-26-048248.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026048248/0001628280-26-048248-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026048248/snti-20260714.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-15T11:35:21.408235+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}